Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Capital Expenditures (2017 - 2026)

Inspire Medical Systems' Capital Expenditures history spans 10 years, with the latest figure at $9.7 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 197.25% to $9.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.2 million, a 835.58% increase, with the full-year FY2025 number at $4.8 million, up 40.96% from a year prior.
  • Capital Expenditures hit $9.7 million in Q1 2026 for Inspire Medical Systems, up from -$476000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for INSP hit a ceiling of $9.7 million in Q1 2026 and a floor of -$4.1 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $2.6 million across 5 years, with a median of $2.5 million in 2025.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 161933.33% in 2023 and later crashed 580.0% in 2025.
  • Tracing INSP's Capital Expenditures over 5 years: stood at -$4.1 million in 2022, then surged by 296.94% to $8.0 million in 2023, then tumbled by 100.87% to -$70000.0 in 2024, then crashed by 580.0% to -$476000.0 in 2025, then skyrocketed by 2143.28% to $9.7 million in 2026.
  • Business Quant data shows Capital Expenditures for INSP at $9.7 million in Q1 2026, -$476000.0 in Q4 2025, and -$540000.0 in Q3 2025.